生物制药企业莱斯康制药（Lexicon Pharmaceuticals）近日宣布与海格投资（Hercules Capital）达成一项创新型贷款协议。该融资方案最引人注目的特点是设置了长达18个月的先息后本期，在此期间企业仅需支付利息，无需偿还本金。
根据协议条款，在初始18个月期限届满后，莱斯康制药还享有两次为期六个月的展期选择权。这种灵活的安排为企业提供了充足的现金流缓冲空间，使其能够更专注于核心药物研发业务的推进。
此项融资安排体现了投资机构对莱斯康制药研发管线价值的认可。通过优化债务结构，企业得以在保持研发投入的同时有效管理财务风险，为未来业务拓展奠定坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.